Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Cancer Immunology, Immunotherapy : CII|December 3, 2013
The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancerNicola E Annels, Victoria E Shaw, Rachel F Gabitass, et al.
Heliyon|December 11, 2023
Multi-omic diagnostics of prostate cancer in the presence of benign prostatic hyperplasiaMatt Spick, Ammara Muazzam, Hardev Pandha, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 12, 2013
Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapseNicolas Boisgerault, Timothy Kottke, Jose Pulido, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirusJian Qiao, Hongxun Wang, Timothy Kottke, et al.
International Journal of Cancer|November 2, 2012
Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cellsRobert A Adair, Karen J Scott, Sheila Fraser, et al.
Nature Medicine|June 21, 2011
Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumorsTimothy Kottke, Fiona Errington, Jose Pulido, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 17, 2024
A randomized phase II trial to examine modified vaccinia Ankara-5T4 vaccine in patients with relapsed asymptomatic ovarian cancer (TRIOC)Agnieszka Michael, William Wilson, Sunny Sunshine, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 VirusNicola E Annels, Mehreen Arif, Guy R Simpson, et al.
Nature Medicine|November 19, 2013
Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrenceTimothy Kottke, Nicolas Boisgerault, Rosa Maria Diaz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 30, 2014
Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory AgentsShane Zaidi, Miran Blanchard, Kevin Shim, et al.
Pageof 15